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Animal mitochondrial protein synthesis factors elon- 
gation factor (EF) Tu and EF-Ts  have been purified as 
an  EF-Tu-Ts complex from crude extracts of bovine 
liver mitochondria. The mitochondrial complex has 
been purified 10,000-fold to near homogeneity by a 
combination of chromatographic procedures including 
high performance liquid chromatography. The mito- 
chondrial EF-Tu*Ts complex is  very stable and cannot 
be dissociated even in the presence of high concentra- 
tions of guanine nucleotides. No guanine nucleotide 
binding to  this complex can be observed in the standard 
nitrocellulose filter binding assay. Mitochondrial EF- 
TS activity can be detected by its  ability  to  facilitate 
guanine nucleotide exchange  with Escherichia  coli EF- 
Tu. The EF-Tumt exhibits similar levels of activity on 
isolated mammalian mitochondrial and E. coli ribo- 
somes, but displays minimal activity on Euglena gra- 
cilis chloroplast 70 S ribosomes and has  no detectable 
activity on wheat germ cytoplasmic ribosomes. In con- 
trast to the bacterial EF-Tu and the EF-Tu from the 
chloroplast of E.  gracilis, the  ability of the mitochon- 
drial factor to  catalyze polymerization is not inhibited 
by the antibiotic kirromycin. 
Mammalian mitochondria contain  a unique protein-synthe- 
sizing system that is distinct from that of the cell cytoplasm. 
Presently,  there is limited information available on the  trans- 
lation process in this organelle, although some progress has 
been made in  the study of mitochondrial tRNAs  and ribo- 
somes. Many mitochondrial tRNAs have structural features 
which differ from the classical tRNA cloverleaf. Animal mi- 
tochondrial ribosomes are characterized by surprisingly low 
sedimentation coefficients (55-60 S) reflecting an unusually 
low ratio of ribosomal RNA to protein (1). They contain only 
two rRNA species (12 S in the small subunit and 16 S in  the 
large subunit) and apparently lack the 5 S rRNA found in 
most other ribosomes (1-3). Animal mitochondrial ribosomes 
are active only with the homologous translocase,  exhibiting 
no activity with other translocases that have been tested. In 
contrast,  the 55 S ribosomes have been shown to be active in 
a  poly(U)-directed in uitro translation system, with EF-Tu’ 
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from Escherichia coli, Bacillus subtilis, and Euglena gracilis 
chloroplasts. No interaction is detectable between the mito- 
chondrial ribosomes and  the wheat germ cytoplasmic EF-1 
(4). 
The most extensively studied mitochondrial elongation fac- 
tor is the EF-Tu from the mitochondria of Saccharomyces 
cereuisiae (5-8). The gene for this factor has been cloned and 
sequenced (7),  and recently Rosenthal and Bodley (8) reported 
the purification and initial  characterization. The affinity con- 
stants of yeast EF-Tu,, for guanine nucleotides are 3-4 orders 
of magnitude weaker than those of the E. coli factor. The 
yeast mitochondrial EF-Tu does not  appear to necessitate a 
guanine nucleotide recycling factor, such as EF-Ts. These 
differences probably represent  a  variation in  the functioning 
of EF-Tu in elongation between the mitochondrial cycle and 
the E. coli cycle. It should be noted that no factor equivalent 
to  the prokaryotic EF-Ts  has been reported from any mito- 
chondrial  system to date. 
In  this paper we describe the purification and initial char- 
acterization of the elongation factors EF-Tu  and  EF-Ts,  in 
the form of an  EF-Tu. Ts complex, from bovine liver mito- 
chondria. We have examined the ability of these elongation 
factors to interact with both homologous and heterologous 
ribosomes. This report  represents the first  identification of a 
mitochondrial factor exhibiting an activity corresponding to 
that of the prokaryotic EF-Ts. 
EXPERIMENTAL  PROCEDURES 
Materials 
GTP  and  GDP were obtained from Pharmacia  LKB Biochemicals 
Inc. Poly(U) and E. coli tRNA were from Boehringer Mannheim. 
Phenylmethylsulfonyl fluoride, DEAE-Sepharose, SP-Sepharose, G -  
75 Sephadex, phosphoenolpyruvate, glycerol and pyruvate kinase 
were from Sigma. The HCA column (Mitsui  Toatsu) was purchased 
from Rainin and TSKgel  DEAE-5PW column was purchased from 
Beckman. Nitrocellulose membrane filter paper type HA (0.45-pm 
pore size) was from Millipore Corp. Pure nitrocellulose membrane 
filter  paper was purchased from Schleicher & Schuell. Centriprep-10, 
Centricon-10, and YM-10 membranes were obtained from Amicon 
Corp. [14C]Phenylalanine, [3H]GDP, and [3H]GTP were obtained 
from Du Pont-New England Nuclear and [“CIPhe-tRNA was pre- 
pared as described by Ravel and Shorey  (9)  using synthetases  pre- 
pared by the method of Muench and Berg (10). Kirromycin was 
kindly supplied by Dr. L. I. Slobin (University of Mississippi). Kir- 
romycin was stored a t  -20 “C  as a 3.1 mM solution in ethanol. Its 
concentration was determined as previously reported (11). When 
required, dilutions of the stock  solution were made in 20% ethanol 
(v/v). The concentration of ethanol in the polymerization assays was 
no  greater than 2%. Buffer A was 20 mM Tris-HC1 (pH 7.6), 40 mM 
KCl, 1 mM MgC12, 0.1 mM EDTA, 6 mM 8-mercaptoethanol, 10% 
glycerol, 1.0 pM GDP; Buffer B was 20 mM MES-KOH  (pH 6.5), 40 
mM KC1,l mM MgC12, 0.1 mM EDTA, 6 mM P-mercaptoethanol,  10% 
glycerol, 1.0 p M  GDP; Buffer C was 20 mM Hepes-KOH (pH 7.0), 40 
mM KC1, 1 mM MgC12, 6 mM P-mercaptoethanol, 10% glycerol, 1.0 
p~ GDP;  Buffer  D was  20 mM Hepes-KOH (pH 7.0), 40 mM KC1, 1 
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mM MgC12, 0.1 mM EDTA, 6 mM 0-mercaptoethanol,  10% glycerol, 
1.0 pM GDP. 
Preparation of Bacterial,  Cytoplasmic,  and Organellar Ribosomes 
and  Elongation  Factors 
E. coli ribosomes, wheat germ 40 S and 60 S ribosomal subunits, 
and E. gracilis chloroplast ribosomes were prepared as described 
previously (12-14). Elongation  factors EF-G,  EF-Tu,  EF-Ts,  and  an 
EF-Tu.  Ts complex were isolated from E. coli (15) and  further purified 
as described (4). Partially purified mitochondrial EF-G was kindly 
provided by J. H. Chung  (University of North Carolina). Wheat Germ 
EF-1  and  EF-2 were prepared as described (4). 
Preparation of Bovine  Liver  Mitochondria 
and  Mitochondrial  Ribosomes 
Livers were typically obtained from male Angus cattle (red or 
black)  and were put in ice within 15 min after  the  death of the animal. 
All subsequent procedures were carried out at  4 "C and all  samples 
were kept  on ice as much as possible. The digitonin-treated bovine 
liver mitochondria from 3-4 kg of tissue were isolated basically as 
described by Matthews et al. (1). The isolated mitochondrial  pellets 
were then frozen in a dry ice/isopropyl alcohol bath  and stored at  
-70 "C. The  total mass of the mitochondria  obtained typically rep- 
resented 3.5% of the initial liver mass. Mitochondrial ribosomes were 
prepared as described by Matthews et al. (1) with modifications 
described by Eberly et al. (4). 
Purification of Bovine  Liver  Mitochondrial E F - T u .   T s  
Mitochondrial extracts containing EF-Tu,  EF-G,  and  EF-Ts  ac- 
tivities were prepared from mitochondria that were used as soon as 
possible following isolation. All procedures described below were 
carried  out a t  4 "C. For the preparation of these factors  about 30 g of 
mitochondria were resuspended in 120  ml of Buffer A  containing 0.1 
mM phenylmethylsulfonyl fluoride, and sonicated on ice with  a Bran- 
son Model 185 sonicator using five 20-s bursts at  5-10 watts with 40- 
s cooling periods. The homogenate was subjected to centrifugation a t  
30,000 X g for 45 min. The supernatant fraction (S30) was either 
used immediately or frozen in a dry ice/isopropyl alcohol bath  and 
stored at  -70 "C. Attempts to scale-up  these procedures using larger 
amounts of mitochondria were unsuccessful due to  the lability of EF- 
Step I: DEAE-Sepharose-The S30 from two sonicated homoge- 
nates (approximately 5.0-6.0 g of protein) was applied, at  a flow rate 
of about 1-2 ml/min, to a 100-ml DEAE-Sepharose fast flow column 
(17.5 X 2.7 cm)  equilibrated  with Buffer A. The column was washed 
in Buffer A until  the A z ~  was less than 0.1 and  then developed with 
a  1-liter  linear  gradient of  0.04 to 0.50 M KC1 in Buffer A. Fractions 
(10 ml) were collected at a flow rate of  2.0 ml/min. Fractions  contain- 
ing EF-Tu activity were pooled and dialyzed for 6 h  against  2  changes 
of Buffer B. The sample was then frozen in a dry ice/isopropyl alcohol 
bath  and stored at  -70 "C. 
Step 2: SP-Sepharose-The sample (approximately 1.70  g) of pro- 
tein was applied to a 20 ml SP-Sepharose column (6.0 X 1.45 cm) 
equilibrated with Buffer B at  a flow rate of 1.0 ml/min. The column 
was then washed with Buffer B until  the absorbance at 280 nm was 
less than 0.1. The column was developed with a  linear  gradient (200 
ml) from 0.04 to 0.40 mM KC1 in Buffer B. Fractions (2.0 ml) were 
collected at  a flow rate of 1.0 ml/min. Active fractions were pooled 
and dialyzed against two changes of Buffer C, fast frozen, and stored 
as described above. 
Step 3: Mitsui Toatsu HCA-Following chromatography on SP- 
Sepharose the sample was further purified by HPLC chromatography 
on hydroxylapatite, CAl,,(P04)~(OH)2. The HCA column (10 X 7.5 
mm) was equilibrated with Buffer C. The sample (56 mg) was applied 
to  the column at a flow rate of 1.0 ml/min. The column was then 
washed with Buffer C until  the AZm returned  to base line. A  linear 
gradient (0-100 mM potassium  phosphate (pH 7.0) in Buffer C) was 
run at 0.3 ml/min for 90 min. Fractions were collected at 1.2-min 
intervals (0.36 ml). Active fractions were pooled and concentrated by 
Amicon's Centriprep-10 and stored  as described above. Prior  to  the 
next  chromatography step  the sample was dialyzed against Buffer D. 
Step 4: TSKgel  DEAE-5P W-The HCA-purified sample was then 
further purified by anion exchange HPLC chromatography on 
TSKgel DEAE-5PW. The column (7.5 X 7.5 mm) was equilibrated 
with Buffer D and  the sample (6.0 mg)  was applied to  the column at 
a flow rate of 0.75 ml/min. The column was then washed with Buffer 
D until the A,,, returned  to base line. The gradient was developed in 
Tumt. 
three steps; the first  gradient  went from 40 to 51.5 mM KC1 in Buffer 
D for 30 min. The column was then washed with 51.5 mM KC1 in 
Buffer D for 23 min. Finally a linear gradient was run for 60 rnin 
from 51.5 to 90 mM KC1 in Buffer D. Fractions were collected at  1.2- 
min intervals (0.36 ml). Centricon-10 was used to concentrate the 
pooled fractions which were then  stored  as described above. 
Step 5: TSKgel DEAE-5PW-The anion exchange purified sample 
was then  further separated by repeating the  HPLC  anion exchange 
chromatography on the TSKgel DEAE-5PW column. The column 
(7.5 X 7.5 mm) was equilibrated  with Buffer D  prior to loading the 
sample. In order to reduce the concentration of  KC1 in the sample to 
40 mM, it was diluted  with Buffer D  minus KCl. The sample (0.26 
mg) was then applied to  the column at a flow rate of 0.3 ml/min. The 
column was washed with Buffer D until  the A2W returned  to base line. 
The column was developed in  three steps: first, a  linear  gradient from 
40 to 54 mM KC1 in Buffer D for 30 min; second, a wash with 54 mM 
KC1 in Buffer D for 3 min; third, a  gradient was run for 60 min going 
from 54 to  85 mM KC1 in Buffer D. The fractions were collected at  
1.0-min intervals (0.30 ml) and Centricon-10 was used to  concentrate 
the pooled sample, which was then stored as described above. 
Alternative  Purification of EF-Tu/Ts,, 
Following the  SP-Sepharose column (Step 2), the active  fractions 
were pooled, concentrated, and dialyzed against Buffer D. The sample 
was then applied to two sequential  passes  through the TSKgel  DEAE- 
5PW column equilibrated in Buffer D. The two  columns were devel- 
oped with the same stepwise gradient; first, a linear  gradient of  40- 
54 mM KC1 in Buffer D using  a flow rate of 0.3 ml/min for 30 min; 
second, a wash with 54 mM KC1 in Buffer D for 15 min; finally, a 
linear  gradient from 54 to 85 mM KC1 in Buffer D at  a flow rate of 
0.25 ml/min for 120 min. The fractions (250 pl) were assayed for 
activity in polymerization and  the active  fractions pooled and  con- 
centrated using  Centricon-10  concentrators. 
Effect of Nucleotides  on  the  EF-Tu/Ts Complex 
A  Sephadex  G-75 gel filtration column (19.3 X 8.6 mm) was 
equilibrated in Buffer D containing 1.0 mM GTP and 10 mM MgC12, 
1.0 mM GDP  and 10 mM MgClZ, or no  guanine nucleotides and no 
MgC12. Samples (100 pl, 3300 units of EF-Tu.Ts,J containing 100 
mg/ml bovine serum  albumin were applied to  the column which was 
developed with the appropriate buffer at  either  4 or 25 "C. Fractions 
(approximately 130 pl) were collected and assayed by poly(U)-directed 
polymerization activity for EF-Tu activity and were also analyzed for 
the protein profile of BSA by using the Coomassie dye absorbance 
ratio (AW/A465) (16). 
Assays 
EF-Tu,, was detected by its ability to replace the corresponding 
E. coli factor in poly(U)-directed polymerization of phenylalanine on 
E. coli ribosomes. Assay mixtures (0.1 ml) contained 50 mM Tris-HC1 
(pH 7.8), 60 mM KC1, 6.5 mM MgC12, 0.1 mM spermine, 1 mM 
dithiothreitol, 2.5 mM phosphoenolpyruvate, 0.17 units of pyruvate 
kinase, 0.5 mM GTP, 12.5 pg  of poly(U), 35 pmol of ["CIPhe-tRNA, 
1.9 pg of partially purified E. coli EF-G, and 0.48 A260 of E. coli 
ribosomes. Incubation was carried out for 30 min at  37 'C and  the 
reaction was terminated by the addition of 5% trichloroacetic acid. 
Incorporation of ['4C]phenylalanine into polypeptide was determined 
essentially as described (9). One unit is defined as the incorporation 
of 1 pmol of ['4C]phenylalanine into polypeptide. Blanks (0.3-0.4 
pmol)  representing the  amount of label retained on the filter in  the 
absence of EF-Tu.  Tsmt have been subtracted from each value. 
Polymerization  assays on mitochondrial ribosomes were similar to 
those described above except that the concentration of  KC1 was 
reduced to 45 mM, and  the concentration of  MgCL was increased to 
12 mM, and  saturating  amounts (14.0 pg) of partially  purified  mito- 
chondrial EF-G replaced E. coli EF-G. 
Mitochondrial EF-Ts activity was measured by testing the ability 
of EF-Ts,, to stimulate  the exchange of guanine nucleotides by E. 
coli EF-Tu  as described by Fox et al. (17) using 0.3 p M  E. coli EF-Tu. 
For  testing nucleotide binding, EF-Tu  .Tsmt  (at  the indicated levels) 
was incubated for 10 min at  37 or 0 "C in a final volume of 50 pl 
containing 25 mM Tris-HC1 (pH 7.8), 50 mM NHICI, and 10 mM 
MgClz containing  either 50 p M  [3H]GDP  or 50 p M  [3H]GTP with 0.54 
pg  of pyruvate  kinase and 1.0 mM phosphoenolpyruvate. The reaction 
was terminated by placing the samples on ice and diluting them with 
3.0  ml  of buffer containing  10 mM Tris-HC1 (pH 7.41, 10 mM MgCL, 
and 10 mM NH4C1. The samples were then filtered through pure 
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nitrocellulose membranes and  the filters and  tubes were rinsed three 
times with the same buffer. The filters were subsequently  dried and 
counted (9). 
Protein concentrations,  using bovine serum albumin as a standard, 
were determined by one of several procedures including the procedure 
of Lowry et al. (B), the modification of this procedure developed by 
Bensadoun and Weinstein (19), or by the method of Sedmak and 
Grossberg (20)  with modifications by Bearden (16). 
RESULTS AND DISCUSSION 
Identification of Bovine Liver Mitochondrial Elongation Fac- 
tors-Crude mitochondrial extracts can replace E. coli EF-Tu 
in polymerization, indicating that these extracts have a  factor 
equivalent to E. coli EF-Tu  (data not  shown). They will also 
enhance GDP exchange activity with E. coli EF-TU, suggest- 
ing that they contain a factor equivalent to  EF-Ts.  In our 
hands extracts exhibiting maximal polymerization activity 
are obtained from the livers of red or black male Angus cattle 
and  it is important  that  the liver be placed in ice within  one- 
half hour following the slaughter of the animal. The activity 
of the crude extracts in polymerization is quite labile. The 
loss of activity is due to  the instability of EF-Tumt (Ref. 4, 
and  data not shown). Because of the lability of this factor, we 
have used mitochondria within 1 week  following preparation. 
Furthermore, we have eliminated the preparation of a post- 
ribosomal supernatant, a step usually involved in the isolation 
of elongation factors from other sources. In addition, we have 
omitted the dialysis of the crude extract  and have processed 
thawed samples as rapidly as possible. When necessary, stor- 
age at  -70 “C can be tolerated for a brief period of time. 
Purification of the Mitochondrial EF-Tu. Ts Complex-As 
indicated below, the activities of mitochondrial EF-Tu  and 
EF-Ts are present in a complex. The purification of this 
complex includes both conventional liquid chromatography 
and HPLC. Chromatography of mitochondrial extracts on 
DEAE-Sepharose results in the separation of EF-Tu.Ts,, 
from EF-G,, (data not shown). The EF-Tu,, activity can be 
recovered in a 93% yield and purified approximately 7-fold  by 
this procedure (Table I).  It  has been observed that  the  EF- 
Turnt activity is stable following the DEAE-Sepharose column 
suggesting that its lability in crude extracts is due to the 
presence of degradative enzymes even when extracts  are pre- 
pared in  the presence of protease  inhibitors.  Fractions con- 
taining EF-Tu, also exhibit EF-Ts, activity  indicating that 
these two factors might be present as a complex. This idea is 
supported by the observation that both activities elute to- 
gether with an  apparent M ,  of 60,000 on gel filtration resins 
(data not  shown).  These two activities also co-purify in the 
steps outlined below. It should be noted that,  in  contrast  to 
prokaryotic systems, no free EF-Tu,, or free EF-Ts,, can be 
detected in mitochondrial preparations. 
Following the isolation of the complex  by DEAE-Sepharose 
chromatography, the sample is further purified by chromatog- 
raphy on  SP-Sepharose. This procedure results in  an 18-fold 
purification with a recovery of 72% (Table  I).  Further purifi- 
cation is then carried out by HPLC.  In  the first of the  HPLC 
steps the partially purified EF-Tu.Ts,, is applied to a HCA 
column (Mitsui Toatsu), which is a form of hydroxylapatite 
designed specifically for the HPLC. The complex is eluted 
with a linear gradient of potassium phosphate. This step 
results  in approximately 6-fold purification with 57% recovery 
of mitochondrial EF-Tu activity (Table I). The sample is 
further purified on an anion exchange column, TSKgel 
DEAE-5PW. This column is developed using a stepwise pro- 
cedure (Fig. 1A) in order to optimize the separation. This step 
results  in  a 10-fold purification with 42% recovery of activity 
(Table I). An additional pass of the sample through the 
TSKgel  DEAE-5PW column with slight modifications of the 
gradient conditions (Fig. 1B) results  in  a further %fold puri- 
fication with 66% recovery of EF-Tu activity (Table 1). The 
overall purification procedure results in 11,000-fold purifica- 
tion of the complex from crude mitochondrial extracts and 
approximately 10.5% of the initial EF-Tu,, polymerization 
activity is recovered. The specific activity observed with the 
purified sample is comparable to  that which is obtained  with 
purified E. coli EF-Tu.Ts (data not shown). The purified 
mitochondrial EF-Tu.  Ts is very labile and protein  concentra- 
tions of greater than 2.5 mg/ml are required to maintain 
activity during  storage and all  subsequent  dilutions of mate- 
rial are routinely done with buffer containing 50 mg/ml BSA 
unless otherwise noted. 
The purified complex was then analyzed by SDS-polyacryl- 
amide gel electrophoresis (Fig. 2 A ,  Lane 3 ) .  The results show 
two protein bands corresponding to a molecular weight of 
46,000 and 27,000. These  bands co-purify with the  EF-Tu. 
Tsmt complex activity throughout the scheme described above. 
By using E. coli EF-Tu (Fig. 2 A ,  Lune 2 )  as a molecular weight 
marker, the mitochondrial EF-Tu migrates at  a slightly higher 
molecular weight band  than  the corresponding prokaryotic 
factor. The mitochondrial EF-Ts has a molecular weight 
almost  identical to  that of E. coli EF-Ts ( M ,  26,000). Densi- 
tometric analysis of the gel indicates  a 1:1 stoichiometry for 
Subsequent to developing the above purification scheme it 
became difficult to obtain the HCA column. Consequently a 
modification of the above procedure was developed (see “Ex- 
perimental Procedures”). Without the HCA step, EF-Tu. 
Ts,, is not  as cleanly separated from contaminating  proteins 
by TSKgel  DEAE-5PW chromatography. The  front portion 
representing 30% of the recovered activity is obtained ap- 
proximately 75% pure as indicated by a specific activity of 
410,000 units/mg and by SDS-PAGE (Fig. 2B, Lane 3 ) .  The 
remaining EF-Tu. Ts,, has a specific activity of  225,000 units/ 
mg and is estimated to be 45% pure (Fig. 2B, Lanes 4 and 5). 
The Affect of Guanine Nucleotides on the Mitochondrial 
Complex-E. coli EF-Tu.Ts complex is readily dissociated 
into  an  EF-Tu.GDP complex and  EF-Ts during the elonga- 
tion cycle in E. coli. We have tested the ability of guanine 
nucleotides to dissociate the mitochondrial complex by sub- 
EF-TU  to  EF-Ts. 
TABLE I 
Purification  of bovine liver mitochondrial EF-Tu 
Step  Protein  Total  units Specific Total 
activity recovery 
Purification 
mg X I O - ~  units f m g  % -fold 
Mitochondrial extract 13,000 554 42.6 100 
513 
1 
DEAE-Sepharose 1,700 302 93 
371 
7 
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FIG. 1. Elution profiles of mitochondrial EF-Tu-Ts on 
TSKgel DEAE-5PW. A, a concentrated sample of EF-Tu-Ts,, 
purified by HCA chromatography was subjected to chromatography 
on TSKgel DEAE-5PW as described under “Experimental Proce- 
dures.” B, the  TSKgel  DEAE-5PW purified sample was then sub- 
jected to a second chromatographic  procedure  utilizing this  HPLC 
anion exchange  column  with  a  slightly modified gradient as described 
under “Experimental  Procedures.” Fractions (1.0 PI)  were tested for 
mitochondrial EF-Tu  activity (0). The absorbance a t  280 nm (-) 
was monitored  with an ISCO UA-5 absorbance  monitor. The conduc- 
tivity  measurements (---) were done  using  a  Radiometer  Conductiv- 
ity Meter Model CD80. 
jecting this complex to gel filtration chromatography in the 
presence and absence of guanine  nucleotides.  For these ex- 
periments, BSA was  used as a molecular  weight marker, and 
to stabilize the EF-Tu,, during the chromatography. As in- 
dicated in Fig.  3A, in the absence of guanine  nucleotides, the 
EF-Tu, activity elutes near the void  volume of the column 
indicating that  it is present in a complex  with EF-Ts,. When 
chromatography is carried out in the presence of high  concen- 
trations of either GDP (Fig. 3B) or GTP (Fig. 3C) there is  no 
shift in the chromatography  position of EF-Tumt, indicating 
that no  dissociation of the  EF-Tu - Ts,, complex has occurred. 
Similar results are obtained when chromatography is carried 
out at either 25 or 4 “C. 
The mammalian mitochondrial EF-Tu - Ts complex appears 
to be extremely stable to dissociation  compared to its prokar- 
yotic and organellar counterparts (23, 24). The E. coli EF- 
Tu. TS complex,  for  example,  is  completely  dissociated  in the 
presence of less than 1 p~ GDP (25). It is possible that 
guanine nucleotide exchange in animal mitochondria may 
occur by a mechanism that is not completely  analogous to 
that observed  in E. coli.  One clear  exception to  the mechanism 
used by E. coli has been reported (26). In this system, that of 
Thermus thermophilus, the  EF-Tu.Ts complex is extremely 
difficult to dissociate, requiring chromatography on a Sepha- 
A. B. 
n - 
I 2 3  1 2 3 4 5  
FIG. 2. SDS-PAGE analysis of mitochondrial EF-Tu*Ts. A, 
mitochondrial EF-Tu.Ts purified to near homogeneity. Lane 1 con- 
tains standard molecular weight markers: bovine serum albumin 
(66,000); hen  ovalbumin (45,000); chymotrypsinogen  A (25,000). Lane 
2, partially purified E. coli EF-Tu (0.17 pg); Lane 3, mitochondrial 
EF-Tu.Ts (0.21 pg). E ,  mitochondrial EF-Tu.Ts purified by the 
alternative purification scheme. Lane I ,  contains  standard molecular 
weight markers: as above; Lane 2, partially purified E. coli EF-Tu 
(0.17 pg); Lane 3, front portion of the mitochondrial EF-Tu peak 
(0.25 pg); Lane 4, middle region of peak  from DEAE-5PW (0.25 pg); 
Lane 5, tailing edge of EF-Tu,, peak (0.25 pg). Polyacrylamide gel 
electrophoresis  (12%  acrylamide and 0.3% bisacrylamide running gel 
with  a 3% stacking gel) was carried out according to Laemmli  (21) 
on a  Bio-Rad  Mini Protean  apparatus.  The gel was developed with 
silver stain (22). 
dex  G-200  column in the presence of 8 M guanidine HCl(26). 
In  this organism, GDP present in an EF-Tu. GDP complex  is 
thought to exchange directly with GTP present in an  (EF- 
Tu .Ts. GTP), dimer  (27). 
The prokaryotic EF-Tu is  generally detected by its ability 
to bind  guanine  nucleotides  (23). In  contrast to the observa- 
tion with the bacterial factors, the mitochondrial EF-Tu in 
the  EF-Tu. Ts,, complex  displays no GTP binding activity 
(Fig. 4A) as determined by nitrocellulose filter binding. Fur- 
thermore, no GDP binding activity is observed with the 
mitochondrial complex  by this method  (Fig. 4B). 
Activity of Mitochondrial EF-Ts in the EF-TU-Ts Com- 
pkx-As indicated above, we generally  measure the activity 
of the complex by assaying for the ability of the EF-Tu, 
component to function in  polymerization. The lack of guanine 
nucleotide  binding activity of the complex  in the nitrocellulose 
filter binding assay has allowed us to measure the EF-Ts 
activity present, by its ability to stimulate GDP exchange 
with E. coli EF-Tu. As indicated in Fig. 5A substantial nu- 
cleotide  exchange activity is  observed when E. coli EF-Tu. 
GDP is incubated with the mitochondrial complex in the 
presence of [3H]GDP. The degree of stimulation obtained is 
similar to  that observed  when E. coli EF-Ts is added to  the 
E. coli EF-Tu incubation mixture (data not shown). These 
observations raise the question of  how the mitochondrial EF- 
TS in the complex can facilitate the exchange of GDP with 
E. coli EF-Tu. One explanation for this observation arises 
from the fact that  the EF-Tu.Tsmt complex is diluted in the 
absence of BSA when it is  used  in the nucleotide  exchange 
assay  with E. coli EF-Tu. As indicated in Fig.  5B, under these 
conditions the activity of the mitochondrial  complex  in  po- 
lymerization  is  less than 30% of that observed  when dilution 
is carried out in the presence of BSA. These results imply 
that greater than 70% of the EF-Tumt has been inactivated. 
Under these conditions EF-Tsmt is  capable of forming a com- 
plex with E. coli EF-Tu as indicated by gel filtration chro- 
matography?  When EF-Tumt is maintained in the active  form, 
* G. H. Spremulli,  unpublished  observations. 
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FIG. 3. Sephadex G-75 profile of 
EF-Tu-TS,, i n  the presence and  ab- 
sence of guanine  nucleotides.  Puri- 
fied mitochondrial EF-Tu.Ts complex 
was subjected to chromatography on 
Sephadex G-75 in the presence and ab- 
sence of guanine nucleotides as described 
under “Experimental Procedures.” Frac- 
tions (20 p l )  were tested for mitochon- 
drial EF-Tu activity (0). The absorb- 
ance profile of  BSA (0) was determined 
as described under “Experimental Pro- 
cedures.” 
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FIG. 4. Analysis of the ability of the mitochondrial  complex 
to  interact  with  guanine  nucleotides. Guanine nucleotide binding 
activity of the EF-Tu.Ts,, complex at both 0 and 37 “C (B) and E. 
coli EF-Tu  at 37 “C (0). Reaction mixtures contained 50 pM [3H1 
GTP ( A )  and 50 p~ [3H]GDP ( B ) .  
no  exchange  with E. coli EF-Tu is  detectable.* T h u s  EF-Ts,, 
appears to be capable of recognizing  the  prokaryotic  EF-Tu 
as well as its  homologous  factor,  implying that mitochondrial 
EF-Tu has certain  features that are  homologous to those of 
the bacterial  factor. 
Activity of Mitochondrial EF-Tu on Various Ribosomes- 
T h e  ability of purified  mitochondrial  EF-Tu. Ts t o  catalyze 
in  vitro  poly(U)-directed  polymerization  has  been  examined 
on 70 S bacterial and organellar ribosomes and on 80 S 
eukaryotic  ribosomes. To compare  its  activity on mitochon- 
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FIG. 5. Activity of mitochondrial EF-Tu-Ts complex. A, 
GDP exchange activity of mitochondrial EF-Tu.Ts in the presence 
and absence of E. coli EF-Tu.  The ability of mitochondrial EF-Ts in 
the complex to catalyze the exchange of guanine nucleotides with E. 
coli EF-Tu was assayed as described under “Experimental Proce- 
dures.” The assay was conducted in the absence (0) and presence (0) 
of 1.2 p g  (20 pmol) of E. coli EF-Tu. B, poly(U)-directed polypheny- 
lalanine polymerization activity of the mitochondrial EF-Tu . Ts com- 
plex. The mitochondrial complex  was assayed for its ability to catalyze 
the in uitro translation of poly(U)-programmed E. coli ribosomes as 
described under “Experimental Procedures.” The assay was con- 
ducted with two different dilutions of the same sample: A, dilution 
into Buffer D (sample that had been used in GDP exchange assay); 
B, dilution into Buffer D containing 50 mg/ml  BSA. 
for the translocation step in the polymerization  assays  with 
both ribosomes. In contrast to previous reports (28), we  have 
observed that the mitochondrial  translocase is active on E.  
coli ribosomes? As indicated  in Fig. 6A, EF-Tu - Tsmt exhibited 
the same degree of activity  on E. coli and mammalian  mito- 
J. H. Chung, unpublished observations. 
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FIG. 6. Activity of bovine mito- 
chondrial EF-Tu on various ribo- 
somes. Reaction mixtures for the 
poly(U)-directed  polymerization were 
incubated with the indicated amounts of 
mitochondrial EF-Tu/Ts  and assayed as 
described under “Experimental Proce- 
dures.” A ,  activity on 0.78 E. coli 
ribosomes (0) and on 0.59 A2, of bovine 
mitochondrial ribosomes (0). B, activity 
of EF-Tu,, on 0.10 A ~ ~ o E .  coli ribosomes 
(0) and on 0.10 A260 of E. gracilis chlo- 
roplast ribosomes (B). The reaction mix- 
ture for assay on chloroplast ribosomes 
was prepared as described under “Exper- 
imental Procedures” except that they 
contained 40 mM KC1 and 18 mM MgC12. 
C, activity of EF-Tumt on 0.25 AZe0 wheat 
germ cytoplasmic ribosomes (A) and 0.30 
A,, E. coli ribosomes (0). Assays on 
wheat germ ribosomes were carried out 
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FIG. 7. Effect of kirromycin on the activity of mitochon- 
drial and E. coli EF-Tu-Ts. Mitochondrial EF-Tu. Ts (0) and E. 
coli EF-Tu.Ts (0) were incubated at  the indicated levels of the 
antibiotic kirromycin and assayed for polyphenylalanine polymeri- 
zation activity as described under  “Experimental Procedures.” 
chondrial ribosomes. In  contrast,  the mitochondrial complex 
displayed very little activity on the 70 S ribosomes from E. 
gracilis chloroplasts (Fig. 6B). This low level of activity is 
quite different from the  substantial activity observed when 
chloroplast EF-Tu was tested  on mitochondrial ribosomes (4). 
Mitochondrial EF-Tu apparently  differs  structurally from the 
E. gracilis chloroplast and prokaryotic EF-Tu since it does 
not efficiently interact with the chloroplast 70 S ribosomes. 
When assayed on wheat germ cytoplasmic ribosomes little 
activity is observed unless high levels of this factor are used. 
These  results  indicate that  the mitochondrial factor does not 
have the features required for efficient interaction with eu- 
karyotic 80 S ribosomes (Fig. 6c). 
Analysis of the Sensitivity of the Mitochondrial EF-Tu. Ts 
Complex  to the Antibiotic Kirromycin-The ability of E. coli 
EF-Tu  to function in the elongation cycle is inhibited by the 
presence of the antibiotic kirromycin. This antibiotic  binds 
to  the prokaryotic factor resulting in  a conformational change 
in  the protein and subsequent  stabilization  of the binding of 
the  EF-Tu.  GTP. aminoacyl-tRNA ternary complex to  the 
ribosome. The hydrolysis of GTP which normally allows the 
dissociation of EF-Tu . GDP from the ribosome does not occur 
and  EF-Tu remains bound to  the ribosome (29). In general, 
EF-Tu/Tsmt, ng 
EF-Tu from prokaryotes is sensitive to kirromycin while the 
activity of cytoplasmic EF-1 is not inhibited by this antibiotic. 
We have tested the ability of this antibiotic  to  inhibit mito- 
chondrial EF-Tu. As indicated in Fig. 7, the mitochondrial 
factor is resistant to inhibition by kirromycin when assayed 
on prokaryotic ribosomes. Similar  results were obtained when 
EF-Tu,,  was assayed with mitochondrial ribosomes (data not 
shown). Interestingly, E. coli EF-Tu was inhibited by kirro- 
mycin even when assayed on mitochondrial ribosomes (data 
not shown). Since kirromycin interferes with the ability of 
prokaryotic factors to dissociate from the ribosome, the fact 
that  the mitochondrial factor is not  inhibited in polymeriza- 
tion by kirromycin could indicate that  the mammalian mito- 
chondrial EF-Tu may remain associated with the ribosome 
during the elongation cycle. It  has also been suggested that 
kirromycin competes with EF-Ts for binding to E. coli EF- 
Tu (11). Since the mitochondrial complex does not appear to 
readily dissociate, it is also possible that a  potential binding 
site for kirromycin on EF-Tu,,  may not  be accessible. 
The work presented here represents the first purification 
and characterization of two translational elongation factors 
from animal mitochondria. These two factors form a very 
tight complex that does not dissociate under  conditions which 
routinely disrupt the corresponding complexes formed by 
their prokaryotic counterparts. However, both of these  factors 
are active in a prokaryotic translation system. The results 
demonstrated here raise interesting  questions  about the se- 
quence of events during the elongation cycle in mammalian 
mitochondria. The precise details of this process are currently 
under investigation. 
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